Curcuma longa (
C. longa) and
Berberis aristata (
B. aristata) are two among the many herbs that have been widely used in traditional medicine for centuries. Turmeric, the powdered form of the rhizome of
C. longa is rich in curcuminoids. Among the curcuminoids, curcumin is the major phenolic component in the rhizomes of
C. longa. The roots of
B. aristata contain significant amounts of the isoquinoline alkaloid berberine. Both the herbs are well known for their anti-inflammatory activity. The aqueous extract of the roots of
B. aristata (500–1000 mg/kg) was found to have a significant anti-inflammatory effect in rats with carrageenan-induced paw edema; the effect was comparable to that of 10 mg diclofenac sodium.
7 The alkaloid berberine from
B. aristata has antibacterial effects and has been found to be useful in cases of trachoma.
8 Berberine has also been found to be effective in experimental herpetic uveitis.
9 Berberine was also shown to abolish acetaldehyde-induced NF-κB activity and cytokine production in HepG2 cells in a dose-dependent manner.
10 Extracts of
C. longa have also exhibited anti-inflammatory effects in standard animal models used for testing anti-inflammatory activity.
11 12 13 Curcumin, a major chemical constituent of
C. longa was found to inhibit leukotriene formation in rat peritoneal polymorphonuclear neutrophils.
14 Possible benefits of oral curcumin supplementation have been observed in cases of chronic anterior uveitis.
15 As in the case of berberine, curcumin exhibits an ability to suppress NF-κB activity and cytokine production in experimental acute liver injury.
16 In view of the potent anti-inflammatory activity of
C. longa and
B. aristata, the present study was designed to investigate the effect of topical application of their aqueous extracts in endotoxin-induced uveitis.